Skip to content

Value to Whom? Incorporating Patient Perspectives into Value Assessment for Novel Cell and Gene Therapies

Share this page

Developed by Health Advances in collaboration with the Partnership to Improve Patient Care and the EveryLife Foundation for Rare Diseases

Related Articles